Frank A. LoBiondo sold Paychex Inc (NASDAQ: PAYX)
Frank A. LoBiondo (R-NJ), a U.S. Representative, has disclosed 1 trade in Paychex Inc (PAYX) since 2017, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Frank A. LoBiondo sold $1,001 - $15,000 of Paychex Inc (NASDAQ: PAYX) on May 17, 2017. Since that trade, PAYX is up +169.46% against the S&P 500 up +262.71%, an outperformance of -93.26%.
Data updated
Frank A. LoBiondo's PAYX trades vs the price
PAYX is up +169.46% since Frank A. LoBiondo sold on May 17, 2017, versus +262.71% for the S&P 500.
Performance since this trade
All Frank A. LoBiondo PAYX trades
Frank A. LoBiondo & PAYX trading FAQ
Is it legal for Frank A. LoBiondo to trade Paychex Inc (PAYX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Paychex Inc (PAYX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Frank A. LoBiondo sell PAYX?
Frank A. LoBiondo disclosed a sale of $1,001 - $15,000 of Paychex Inc (PAYX) on May 17, 2017, according to public STOCK Act filings.
How has PAYX performed since Frank A. LoBiondo's trade?
Since Frank A. LoBiondo sold PAYX on May 17, 2017, the stock is up +169.46%, versus +262.71% for the S&P 500 over the same period, an outperformance of -93.26%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional PAYX trades?
Quantellect tracks every disclosed congressional trade in Paychex Inc (PAYX) on the Paychex Inc congressional trading page, which aggregates filings across all members of Congress.
Frank A. LoBiondo's PAYX tradesAll congressional filings for Paychex IncFrank A. LoBiondo's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.